S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
S&P 500   3,276.24 (+1.01%)
DOW   28,722.85 (+0.66%)
QQQ   221.45 (+1.54%)
AAPL   317.69 (+2.83%)
FB   217.79 (+1.36%)
MSFT   165.46 (+1.96%)
GOOGL   1,450.50 (+1.31%)
AMZN   1,853.25 (+1.36%)
CGC   23.92 (+10.95%)
NVDA   247.97 (+3.23%)
BABA   210.23 (+2.32%)
MU   56.47 (+1.91%)
GE   11.73 (+2.53%)
TSLA   566.90 (+1.59%)
AMD   50.53 (+2.58%)
T   38.58 (+0.86%)
ACB   1.97 (+4.23%)
F   8.97 (+0.90%)
NFLX   348.52 (+1.64%)
BAC   33.24 (+1.19%)
DIS   138.37 (+1.82%)
GILD   64.36 (+0.83%)
Log in

Orgenesis News Headlines (NYSE:ORGS)

$4.83
+0.03 (+0.63 %)
(As of 01/28/2020 04:00 PM ET)
Today's Range
$4.62
Now: $4.83
$4.83
50-Day Range
$2.46
MA: $4.09
$5.40
52-Week Range
$2.35
Now: $4.83
$5.93
Volume18,379 shs
Average Volume51,449 shs
Market Capitalization$78.06 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Orgenesis (NYSE ORGS) News Headlines

Source:
DateHeadline
Orgenesis Inc. Announces $9.2 Million Private PlacementOrgenesis Inc. Announces $9.2 Million Private Placement
finance.yahoo.com - January 21 at 7:48 AM
Orgenesis Appoints Industry Veteran Mario Philips to its Board of DirectorsOrgenesis Appoints Industry Veteran Mario Philips to its Board of Directors
finance.yahoo.com - January 13 at 4:39 PM
Orgenesis Announces Addition of University of California, Davis, to its Point of Care Network; UC Davis Health to Utilize Orgenesis’ Point of Care Platform for the Development, Commercialization and Supply of Cell and Gene Therapy ProductsOrgenesis Announces Addition of University of California, Davis, to its Point of Care Network; UC Davis Health to Utilize Orgenesis’ Point of Care Platform for the Development, Commercialization and Supply of Cell and Gene Therapy Products
finance.yahoo.com - January 10 at 7:19 AM
Orgenesis Announces Receipt of the $6.6 Million Second Milestone Payment into Masthercell Global SubsidiaryOrgenesis Announces Receipt of the $6.6 Million Second Milestone Payment into Masthercell Global Subsidiary
finance.yahoo.com - December 23 at 12:31 PM
Orgenesis and Theracell to Launch Point of Care Cell and Gene Therapy Centers within HYGEIA Group’s Hospital Network in GreeceOrgenesis and Theracell to Launch Point of Care Cell and Gene Therapy Centers within HYGEIA Group’s Hospital Network in Greece
finance.yahoo.com - December 6 at 9:44 AM
Orgenesis Ranked 5th Fastest Growing Technology Company in Maryland and 208th in North America on Deloittes 2019 Technology Fast 500™Orgenesis Ranked 5th Fastest Growing Technology Company in Maryland and 208th in North America on Deloitte's 2019 Technology Fast 500™
finance.yahoo.com - November 26 at 7:18 AM
Orgenesis EPS misses by $0.17, misses on revenueOrgenesis EPS misses by $0.17, misses on revenue
seekingalpha.com - November 8 at 9:14 AM
Orgenesis Third Quarter 2019 Revenue Increases 46% to a Record $9.1 MillionOrgenesis Third Quarter 2019 Revenue Increases 46% to a Record $9.1 Million
finance.yahoo.com - November 8 at 9:14 AM
FDA grants orphan drug designation to Orgenesis insulin therapyFDA grants orphan drug designation to Orgenesis' insulin therapy
seekingalpha.com - June 17 at 10:54 AM
Orgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total PancreatectomyOrgenesis Granted FDA Orphan Drug Designation for Autologous Insulin Producing Cells in the Treatment of Severe Hypoglycemia-Prone Diabetes Resulting from Total Pancreatectomy
finance.yahoo.com - June 17 at 10:54 AM
Orgenesis shares soar 19% premarket after FDA grants orphan designation to insulin techOrgenesis shares soar 19% premarket after FDA grants orphan designation to insulin tech
finance.yahoo.com - June 17 at 10:54 AM
Those Who Purchased Orgenesis (NASDAQ:ORGS) Shares A Year Ago Have A 53% Loss To Show For ItThose Who Purchased Orgenesis (NASDAQ:ORGS) Shares A Year Ago Have A 53% Loss To Show For It
finance.yahoo.com - April 24 at 3:27 PM
Orgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBioOrgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBio
finance.yahoo.com - April 11 at 9:12 AM
Will Orgenesis Inc. (ORGS) Report Negative Q1 Earnings? What You Should KnowWill Orgenesis Inc. (ORGS) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 8 at 3:33 PM
Orgenesis Announces Publication of an Independent Study “The Role of The Vasculature Niche on Insulin Producing Cells Generated by Transdifferentiation of Adult Human Liver Cells” in the Stem Cell Research and Therapy JournalOrgenesis Announces Publication of an Independent Study “The Role of The Vasculature Niche on Insulin Producing Cells Generated by Transdifferentiation of Adult Human Liver Cells” in the Stem Cell Research and Therapy Journal
finance.yahoo.com - April 3 at 9:57 AM
Orgenesis Subsidiary Masthercell Global Announces Plans to Establish New Facility for Cell and Gene Therapy Commercial ManufacturingOrgenesis Subsidiary Masthercell Global Announces Plans to Establish New Facility for Cell and Gene Therapy Commercial Manufacturing
finance.yahoo.com - March 25 at 10:26 AM
Orgenesis Inc. Estimate MomentumOrgenesis Inc. Estimate Momentum
www.nasdaq.com - March 18 at 3:24 PM
Does Orgenesis Inc.’s (NASDAQ:ORGS) CEO Pay Compare Well With Peers?Does Orgenesis Inc.’s (NASDAQ:ORGS) CEO Pay Compare Well With Peers?
finance.yahoo.com - March 7 at 3:22 PM
Orgenesis CEO to Participate in Panel at the 2019 BIO CEO & Investor ConferenceOrgenesis CEO to Participate in Panel at the 2019 BIO CEO & Investor Conference
finance.yahoo.com - February 11 at 9:42 AM
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: Roth IRA

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel